Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EDAX is a global leader in the design and manufacture of high-performance analytical instrumentation for materials characterization. The company specializes in Energy Dispersive Spectroscopy (EDS), Electron Backscatter Diffraction (EBSD), Wavelength Dispersive Spectrometry (WDS), and X-ray Fluorescence (XRF) systems. Within the life sciences and healthcare sectors, EDAX's technology is critical for analyzing the elemental composition and structural properties of biomaterials, pharmaceuticals, and biological tissues. Their solutions enable researchers to detect contaminants, study bone mineralization, and characterize drug delivery systems at the micro and nano scales. As a business unit of AMETEK, EDAX integrates advanced hardware with sophisticated software to provide comprehensive microanalysis capabilities. The company serves a diverse range of markets, including academia, government research, and industrial laboratories worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EDAX.